Cargando…

Targeting BRD9 for Cancer Treatment: A New Strategy

Bromodomain-containing protein 9 (BRD9) is a newly identified subunit of the non-canonical barrier-to-autointegration factor (ncBAF) complex and a member of the bromodomain family IV. Studies have confirmed that BRD9 plays an oncogenic role in multiple cancer types, by regulating tumor cell growth....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiuzuo, Liao, Yi, Tang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769155/
https://www.ncbi.nlm.nih.gov/pubmed/33380808
http://dx.doi.org/10.2147/OTT.S286867

Ejemplares similares